Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 ,inter alia, to consider and approve 1. consider and approve ....
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tatva Chintan Pharma Chem Ltd has informed exchanges about a Board meeting scheduled for 16 May 2026. The meeting will consider and approve the standalone and consolidated audited financial results for Q4 and the financial year ended 31 March 2026. Additionally, the Board will consider recommending a final dividend for FY2026, subject to shareholder approval at the ensuing AGM. The company has also closed its trading window for insiders from 01 April 2026 until 48 hours after the results are made public, as per its insider trading code.
This is a routine board meeting intimation for quarterly and annual results along with dividend consideration. The outcome could be positive for shareholders if dividend is approved, but no specific financial details or guidance are provided in this notice.